![](https://www.genosciencepharma.com/wp-content/uploads/2023/04/protac-Yissum-gns-600x403.jpg)
19 April 2023
Genoscience Pharma has announced a new agreement for research at the Hebrew University of Jerusalem on targeted degradation technology
MARSEILLE-JERUSALEM, April 19, 2023 – Genoscience Pharma a clinical-stage biopharmaceutical company that develops disruptive therapeutics…
Read More